Efficacy and safety of CM310 in moderate to severe asthma: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
Nan Su(Army Medical University), Chen Wang(Kunming University of Science and Technology), Zuke Xiao, Yiyi Jiang(Wenzhou Medical University), Wenjuan Wang(Shijiazhuang Yiling Pharmaceutical (China)), Jie Li(Jining First People's Hospital), Zhihong Chen(Purdue University West Lafayette), Chunxiao Li(University of Cambridge), Xiaomeng Qi(Shijiazhuang Yiling Pharmaceutical (China)), Changqing Lin, Ling Zhang(Obstetrics and Gynecology Hospital of Fudan University), Haihong Wu(Hainan General Hospital), Xiangjie Zhang(Jiangxi Pingxiang People's Hospital), Junzhen Gao(Inner Mongolia Medical University), Shengyu Wang(Hebei Medical University), Jingbo Qiu(Shijiazhuang Yiling Pharmaceutical (China)), Anbo Xiang(Shijiazhuang Yiling Pharmaceutical (China)), Dong Zhang(Baotou Medical College), Liming Peng(Dalian University of Technology)
Cited by 0
Related Papers
RNAscope
|Journal of Molecular Diagnostics|2011|2.7k
Carbon-based electronics
|Nature Nanotechnology|2007|2.5k
Graphene nano-ribbon electronics
|Physica E Low-dimensional Systems and Nanostructures|2007|1.6k
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
|Proceedings of the National Academy of Sciences|2011|824
An Integrated Logic Circuit Assembled on a Single Carbon Nanotube
|Science|2006|570